GUIRGIS, Helmy M..
 Target Therapy vs the Immune Check Point Inhibitors in Lung Cancer: Costs and Caps Platform.
<strong>Medical Research Archives</strong>, [S.l.], v. 11, n. 2, feb. 2023.
ISSN 2375-1924.
Available at: &lt;<a href="https://esmed.org/MRA/mra/article/view/3641" target="_new">https://esmed.org/MRA/mra/article/view/3641</a>&gt;. Date accessed: 25 apr. 2024.
doi: <a href="https://doi.org/10.18103/mra.v11i2.3641">https://doi.org/10.18103/mra.v11i2.3641</a>.